About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials | 6,618 Studies Recruiting

Clinical TrialsLymphoma

Lymphoma Clinical Trials

Browse 6,618 clinical trials for lymphoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1841-1860 of 6,618 trials

CompletedTopotecan and Radiation Therapy in Treating Patients With Solid Tumors or LymphomaPhase I trial to study the effectiveness of topotecan and radiation therapy in treating patients who have solid tumors or lymphoma.NCT00002625·Madison, Wisconsin UnknownIBI376 Plus Rituximab in Patients With Untreated Indolent Lymphoma.Follicular lymphoma (FL) and marginal zone lymphoma (MZL) are the most common inert non Hodgkin's lymphoma (iNHL).NCT05073250·Beijing UnknownChidamide Combined With PECM in Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)To observe the efficacy and safety of Chidamide combined with prednisone, cyclophosphamide, etoposide and methotrexate in relapsed or refractory PTCL.NCT03321890·Guangzhou, Guangdong TerminatedA Study to Assess the Hematopoyetic Response of Anemic Patients With Hematologic Malignancies Treated With Erythropoietin BThis study will examine the efficacy, safety and effect on hemoglobin levels, of once weekly subcutaneous injections of epoetin beta (30,000 IU) in anemic participants with…NCT02608060·Caracas and 1 other

Related Searches

hodgkintrials non-hodgkintrials

Data from ClinicalTrials.govTerms

CompletedDNA Analysis in Influencing Response to Rituximab in Samples From Patients With Follicular Lymphoma Treated on ECOG-E4402RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to…NCT01406782

CompletedIBI376 in Patients With Relapsed or Refractory Follicular Lymphoma/Marginal Zone LymphomaA Phase 2, Multicenter, Open-Label Study of IBI376, a PI3Kδ Inhibitor, in Patients with Relapsed or Refractory Follicular Lymphoma/Marginal Zone LymphomaNCT04298879·Shanghai

CompletedPhase I/Ib Study of Nivolumab & Veliparib in Patients With Advanced Solid Tumors & LymphomaThe purpose of this research study is to determine the highest and safest dose of the experimental drug veliparib when combined with nivolumab.NCT03061188·Chicago, Illinois

RecruitingPersonalized NK Cell Therapy in CBTThis phase II clinical trial studies how well personalized natural killer (NK) cell therapy works after chemotherapy and umbilical cord blood transplant in treating patients with…NCT02727803·Houston, Texas

CompletedPre-phase Treatment Before R-CHOP Chemotherapy in Elderly Patients With Newly Diagnosed DLBCLA phase 2 trial of pre-phase treatment before R-CHOP chemotherapy in elderly patients with newly diagnosed DLBCLNCT03465527·Busan, Sue-gu

Active not recruitingInotuzumab Ozogamicin in Treating Patients With B-cell Acute Lymphocytic Leukemia With Positive Minimal Residual DiseaseThis phase II trial studies how well inotuzumab ozogamicin works in treating patients with B-cell acute lymphocytic leukemia with positive minimal residual disease.NCT03441061·Houston, Texas

Not yet recruitingImmunoglobulin Replacement Therapy (IgRT) Versus Antibiotic Prophylaxis (PA) in Patients Treated by CD19-targeted Chimeric Antigen Receptor (CAR)T Cells for a B Cell Acute Lymphoblastic Leukemia or a B Cell LymphomaB cell (CD19) targeted chimeric antigen receptor modified T Cells (CAR-T) has transformed treatment of relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL) or B-cell…NCT07754682

TerminatedEfficacy, Safety, and Pharmacokinetic Profiles of REGN3500 Administered to Adult Patients With Moderate-to-Severe Atopic DermatitisThe primary objective of the study is to assess the efficacy of REGN3500 monotherapy in Atopic dermatitis (AD), as well as understand the dose-response relationship, compared with…NCT03738423·Birmingham, Alabama and 88 others

Completed506U78 in Treating Patients With LymphomaPhase II trial to study the effectiveness of 506U78 in treating patients who have lymphoma that has not been treated previously or that has not responded to previous treatment.NCT00005080·Chicago, Illinois

CompletedFludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's LymphomaRATIONALE: Drugs used in chemotherapy and hormone therapy use different ways to stop cancer cells from dividing so they stop growing or die.NCT00002779·Scottsdale, Arizona and 19 others

RecruitingOrelabrutinib and Rituximab With Optional Autologous Hematopoietic Stem Cell Transplantation in MCL TreatmentThis multicenter, open-label, trial aims to evaluate the efficacy and safety of orelabrutinib in combination with rituximab with optional autologous hematopoietic stem cell…NCT07199296·Shanghai

UnknownMultiparametric Cardiac MRI in Patients Under CAR T-cell TherapyRecently chimeric antigen receptor (CAR) T-cell therapy, a new class of chemo therapy, has gained regulatory approval for the treatment of diseases such as B-cell lymphoma.NCT05414162·Bonn, North Rhine-Westphalia

CompletedA Trial of Radiotherapy and Durvalumab in DLBCL and FLThe primary objective for this study is to determine the safety profile of radiotherapy and durvalumab, a PD-L1 inhibitor.NCT03610061·Brisbane, Queensland and 2 others

RecruitingPreventive Application of Single-use Negative Pressure Wound Therapy (sNPWT) in the Postoperative Course of Radiotreatated Limb Sarcoma SurgeryPatients will be recruited at the time of the pre-admission visit.NCT06941194·Padova, Italy/Padova

CompletedStudy of YH004 (4-1BB Agonist Antibody) in Advanced or Metastatic MalignancyYH004 is a humanized monoclonal antibody that specifically binds to 4-1BB, and acts as an agonist against 4-1BB.NCT05040932·Wollongong, Australia and 2 others

RecruitingTesting the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell LymphomaThis phase I trial tests the safety, side effects, and best dose of nivolumab in combination with ASTX727 in treating B-cell lymphoma that has come back (relapsed) or does not…NCT05272384·Birmingham, Alabama and 8 others

PreviousPage 93 of 331Next